Post Categories
QPS Global Clinical Operations Team Aces Enrollment for a Global Study of a Prostate Cancer Drug
April 19, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of an investigational…
SCIEX and QPS Join Forces to Bring You a New Bioanalysis Solution for Biologics
April 5, 2016
Over the past 10 years, large molecule therapies have increased from 10% to nearly 50% of the typical pharma and biopharmaceutical pipeline. This transition…
QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells
March 25, 2016
QPS and Samsara Sciences have solidified a cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and…
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th
March 9, 2016
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th. Several members of QPS’ Early Phase Clinical team will be…
QPS is proud to announce that our toxicology facility passed a GLP audit by the US FDA in 3Q 2015 with no major findings.
March 7, 2016
We are exhibiting at SOT 55th Annual Meeting and ToxExpoTM. Please visit our booth (#1813) between March 13-16 at the New Orleans Convention Center,…
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
March 2, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly…
QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study
March 1, 2016
If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse…
QPS Seen As Inspirational for Delaware
February 25, 2016
Where do you turn when you just took the package? 25% of DuPont employees (likely more on the way) got the bad news here…
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
February 15, 2016
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and…
New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database
February 9, 2016
The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last…
See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016
February 5, 2016
On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development…
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
January 6, 2016
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are…
Immune Response Pathway a Possible Target to Treat Alzheimer’s Disease
June 6, 2022
Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 50 million people globally. Projections show that, without a medical intervention,…
Freeze-Dried Mouse Sperm: A Revolution for In Vitro Fertilization?
June 1, 2022
When you think of a scientific laboratory, you might picture high-tech equipment, high-powered centrifuges, and bubbling vats of mysterious chemicals. However, the inner workings…
Stem Cells May Be at the Root of Baldness – As Well As the Cure
May 23, 2022
Within every hair follicle are the stem cells programmed to grow hair. These cells inhabit and grow in a region of the follicle called…
War in Ukraine Impacts Clinical Research Industry
May 18, 2022
Russia’s invasion of Ukraine is causing what the Financial Times called a “many-sided economic shock,” sending global prices sky-high for goods ranging from fuel…
Can LSD Be a Valuable Therapeutic Agent for Anxiety and Depression?
May 16, 2022
The World Health Organization has estimated that the COVID-19 pandemic led to a 25% increase in cases of anxiety disorder worldwide in 2020. As…
Shedding Light on the Dark Proteome
May 9, 2022
More than 20 years ago when researchers shared the human genome sequence, the same scientists counted 20,000 discrete sections, approximately 1% of our DNA,…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
